检索结果 - Samuel A. Funt

Refine Results
  1. 1
    The Role of Neoadjuvant Trials in Drug Development for Solid Tumors

    The Role of Neoadjuvant Trials in Drug Development for Solid Tumors 由 Samuel A. Funt, Paul B. Chapman

    出版 2016
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Systemic, perioperative management of muscle-invasive bladder cancer and future horizons

    Systemic, perioperative management of muscle-invasive bladder cancer and future horizons 由 Samuel A. Funt, Jonathan E. Rosenberg

    出版 2016
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Pegylation of High-Density Lipoprotein Decreases Plasma Clearance and Enhances Antiatherogenic Activity

    Pegylation of High-Density Lipoprotein Decreases Plasma Clearance and Enhances Antiatherogenic Activity 由 Andrew Murphy, Samuel A. Funt, Darren J. Gorman, Alan R. Tall, Nan Wang

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer

    The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer 由 Nick van Dijk, Samuel A. Funt, Christian U. Blank, Thomas Powles, Jonathan E. Rosenberg, Michiel S. van der Heijden

    出版 2018
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes

    Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes 由 Alexander Solovyov, Nicolas Vabret, Kshitij S. Arora, Alexandra Snyder, Samuel A. Funt, Dean F. Bajorin, Jonathan E. Rosenberg, Nina Bhardwaj, David T. Ting, Benjamin D. Greenbaum

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors

    Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors 由 Samuel A. Funt, Sujata Patil, Darren R. Feldman, Robert J. Motzer, Dean F. Bajorin, Joel Sheinfeld, Satish K. Tickoo, Victor E. Reuter, George J. Bosl

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Role of Interleukin 17 in Inflammation, Atherosclerosis, and Vascular Function in Apolipoprotein E–Deficient Mice

    Role of Interleukin 17 in Inflammation, Atherosclerosis, and Vascular Function in Apolipoprotein E–Deficient Mice 由 Meena S. Madhur, Samuel A. Funt, Li Li, Antony Vinh, Wei Chen, Heinrich E. Lob, Yoichiro Iwakura, Yelena Blinder, Ayaz Rahman, Arshed A. Quyyumi, David G. Harrison

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Pretreatment Eosinophil Counts in Patients With Advanced or Metastatic Urothelial Carcinoma Treated With Anti-PD-1/PD-L1 Checkpoint Inhibitors

    Pretreatment Eosinophil Counts in Patients With Advanced or Metastatic Urothelial Carcinoma Treated With Anti-PD-1/PD-L1 Checkpoint Inhibitors 由 José Maurício Mota, Min Yuen Teo, Karissa Whiting, Han A. Li, Ashely M. Regazzi, Chung‐Han Lee, Samuel A. Funt, Dean F. Bajorin, Irina Ostrovnaya, Gopa Iyer, Jonathan E. Rosenberg

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation

    Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation 由 Mohamed A. Saleh, William G. McMaster, Jing Wu, Allison E. Norlander, Samuel A. Funt, Salim Thabet, Annet Kirabo, Liang Xiao, Wei Chen, Hana A. Itani, Danielle L. Michell, Tianxiao Huan, Xiaoyan Zhang, Satoshi Takaki, Jens Titze, Daniel Levy, David G. Harrison, Meena S. Madhur

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology

    PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology 由 Henning Reis, Rene Serrette, Jennifer Posada, Vincent Lu, Ying‐Bei Chen, Anuradha Gopalan, Samson W. Fine, Satish K. Tickoo, S. Joseph Sirintrapun, Gopa Iyer, Samuel A. Funt, Min Yuen Teo, Jonathan E. Rosenberg, Dean F. Bajorin, Guido Dalbagni, Bernard H. Bochner, David B. Solit, Victor E. Reuter, Hikmat Al‐Ahmadie

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Escape from nonsense-mediated decay associates with anti-tumor immunogenicity

    Escape from nonsense-mediated decay associates with anti-tumor immunogenicity 由 Kevin Litchfield, James L. Reading, Emilia L. Lim, Hang Xu, Po Liu, Maise Al-Bakir, Yien Ning Sophia Wong, Andrew Rowan, Samuel A. Funt, Taha Merghoub, David Perkins, Martin Lauss, Inge Marie Svane, Göran Jönsson, Javier Herrero, James Larkin, Sergio A. Quezada, Matthew D. Hellmann, Samra Turajlic, Charles Swanton

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis

    Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis 由 Alexandra Snyder, Tavi Nathanson, Samuel A. Funt, Arun Ahuja, Jacqueline L. Buros, Matthew D. Hellmann, Eliza Chang, Bülent Arman Aksoy, Hikmat Al‐Ahmadie, Erik Yusko, Marissa Vignali, Sharon Benzeno, Mariel Elena Boyd, Meredith Moran, Gopa Iyer, Harlan Robins, Elaine R. Mardis, Taha Merghoub, Jeff Hammerbacher, Jonathan E. Rosenberg, Dean F. Bajorin

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers

    Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers 由 Min Yuen Teo, Kenneth Seier, Irina Ostrovnaya, Ashley Marie Regazzi, Brooke Kania, Meredith Moran, C Cipolla, Mark J. Bluth, Joshua Chaim, Hikmat Al‐Ahmadie, Alexandra Snyder, Maria I. Carlo, David B. Solit, Michael F. Berger, Samuel A. Funt, Jedd D. Wolchok, Gopa Iyer, Dean F. Bajorin, Margaret K. Callahan, Jacob Rosenberg

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies

    IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies 由 Dulce M. Barrios, Gregory S. Phillips, Amaris Geisler, Sabrina Trelles, Alina Markova, Sarah Noor, Elizabeth Quigley, Helen Haliasos, Andrea P. Moy, Alison M. Schram, J. Bromberg, Samuel A. Funt, Martin H. Voss, Alexander Drilon, Matthew D. Hellmann, Elizabeth Comen, Saisindhu Narala, Anisha B. Patel, Megan Wetzel, Jae Yeon Jung, Donald Y.M. Leung, Mario E. Lacouture

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Genomic Differences Between “Primary” and “Secondary” Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy

    Genomic Differences Between “Primary” and “Secondary” Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy 由 Eugene J. Pietzak, Emily C. Zabor, Aditya Bagrodia, Joshua Armenia, Wenhuo Hu, Ahmet Zehir, Samuel A. Funt, François Audenet, David Barron, Noelia Maamouri, Qiang Li, Min Yuen Teo, Maria E. Arcila, Michael F. Berger, Nikolaus Schultz, Guido Dalbagni, Harry W. Herr, Dean F. Bajorin, Jonathan E. Rosenberg, Hikmat Al‐Ahmadie, Bernard H. Bochner, David B. Solit, Gopa Iyer

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma

    Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma 由 Jeppe Sejerø Holm, Samuel A. Funt, Annie Borch, Kamilla Kjærgaard Munk, Anne-Mette Bjerregaard, James L. Reading, Colleen Maher, Ashley Marie Regazzi, Phillip Wong, Hikmat Al‐Ahmadie, Gopa Iyer, Tripti Tamhane, Amalie Kai Bentzen, Nana Overgaard Herschend, Susan De Wolf, Alexandra Snyder, Taha Merghoub, Jedd D. Wolchok, Morten Nielsen, Jonathan E. Rosenberg, Dean F. Bajorin, Sine Reker Hadrup

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade

    LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade 由 Ronglai Shen, Michael A. Postow, Matthew Adamow, Arshi Arora, Margaret Hannum, Colleen Maher, Phillip Wong, Michael A. Curran, Travis J. Hollmann, Liwei Jia, Hikmat Al‐Ahmadie, Niamh M. Keegan, Samuel A. Funt, Gopa Iyer, Jonathan E. Rosenberg, Dean F. Bajorin, Paul B. Chapman, Alexander N. Shoushtari, Allison Betof Warner, Parisa Momtaz, Taha Merghoub, Jedd D. Wolchok, Katherine S. Panageas, Margaret K. Callahan

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition

    IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition 由 Annie Borch, Ibel Carri, Birkir Reynisson, Heli M. Garcia Alvarez, Kamilla Kjærgaard Munk, Alessandro Montemurro, Nikolaj Pagh Kristensen, Siri Tvingsholm, Jeppe Sejerø Holm, Christina Heeke, Keith Moss, Ulla Kring Hansen, Anna‐Lisa Schaap‐Johansen, Frederik Otzen Bagger, Vinicius Araújo Barbosa de Lima, Kristoffer Staal Rohrberg, Samuel A. Funt, Marco Donia, Inge Marie Svane, Ulrik Lassen, Carolina Barra, Morten Nielsen, Sine Reker Hadrup

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor

    Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor 由 Justin Taylor, Mark T.A. Donoghue, Caleb Ho, Kseniya Petrova‐Drus, Hikmat Al‐Ahmadie, Samuel A. Funt, Yanming Zhang, Umut Aypar, Pavitra Rao, Shweta S. Chavan, Michael Haddadin, Roni Tamari, Sergio Giralt, Martin S. Tallman, Raajit K. Rampal, Priscilla Baez, Rajya Kappagantula, Satyajit Kosuri, Ahmet Doǧan, Satish K. Tickoo, Victor E. Reuter, George J. Bosl, Christine A. Iacobuzio‐Donahue, David B. Solit, Barry S. Taylor, Darren R. Feldman, Omar Abdel‐Wahab

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Fundamental immune–oncogenicity trade-offs define driver mutation fitness

    Fundamental immune–oncogenicity trade-offs define driver mutation fitness 由 David Hoyos, Roberta Zappasodi, Isabell Schulze, Zachary Sethna, Kelvin C. de Andrade, Dean F. Bajorin, Chaitanya Bandlamudi, Margaret K. Callahan, Samuel A. Funt, Sine Reker Hadrup, Jeppe Sejerø Holm, Jonathan E. Rosenberg, Sohrab P. Shah, Ignacio Vázquez-Garćıa, Britta Weigelt, Michelle Wu, Dmitriy Zamarin, Laura F. Campitelli, Edward J. Osborne, Mark Klinger, Harlan Robins, Payal P. Khincha, Sharon A. Savage, Vinod P. Balachandran, Jedd D. Wolchok, Matthew D. Hellmann, Taha Merghoub, Arnold J. Levine, Marta Łuksza, Benjamin D. Greenbaum

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: